Cellebrite DI Ltd (NASDAQ:CLBT) does about 883.99K shares in volume on a normal day but saw 2450579 shares change hands in Monday trading. The company now has a market cap of 2.40B USD. Its current market price is $11.67, marking an increase of 10.41% compared to the previous close of $10.57. The 52 week high reached by this stock is $12.50 whilst the lowest price level in 52 weeks is $5.84.
Cellebrite DI Ltd (CLBT) has a 20-day trading average at $11.12 and the current price is -6.64% off the 52-week high compared with 99.93% distance from its 52-week low. The 50-day simple moving average of the closing price is $10.96 and its 200-day simple moving average is $9.29. If we look at the stock’s price movements over the week, volatility stands at 3.94%, which decreases to 3.69% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 61.74 to suggest the stock is neutral.
The consensus objective for the share price is $14.71, suggesting that the stock has a potential upside of 20.67% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on March 28, 2024 when Needham reiterated the stock to “Buy” and issued a price target of between $13 and $13.50. BofA Securities upgraded its price target at $9-$12.
Cellebrite DI Ltd (CLBT) stock is up 11.78% over the week and 3.55% over the past month. Its price is 34.76% year-to-date and 95.81% over the past year.
To reach the target analysts have set, the stock logically needs to grow 20.67 percent from here.
The company has a return on equity of -1768.51%. The forward price to earnings ratio is 49.30. The beta has a value of 1.48. Price to sales ratio is 6.98.
